Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -7 of 7
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/5/2008
 
First Published:
4/23/2004
1.
Phase III Randomized Study of Single-Dose Local Radiotherapy Versus Ibandronate in Patients With Localized Metastatic Bone Pain
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
Over 18
Other
CRUK-NCRI-RT-02-01
EU-20224, RIB, ISRCTN86185157, NCT00082927
Last Modified:
1/14/2009
 
First Published:
7/23/2005
2.
Phase III Randomized Study of Adjuvant Zoledronate Versus Clodronate Versus Ibandronate in Women With Resected Primary Stage I-III Adenocarcinoma of the Breast
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
SWOG-S0307
NCCTG-SWOG-S0307, ECOG-SWOG-S0307, NSABP-SWOG-S0307, CALGB-SWOG-S0307, CAN-NCIC-SWOG-S0307, S0307, NCT00127205
3.
Study in Elderly Patients With Early Breast Cancer (ICE)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
65 and over
Other
GBG32
BIG 4-04, NCT00196859
4.
A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-Positive Primary Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 to 64
Other
GBG 33
GAIN, NCT00196872
Last Modified:
11/12/2007
 
First Published:
5/11/2006
5.
Phase III Randomized Study of Ibandronate Versus Zoledronate in Patients With Newly Diagnosed Bone Metastases Secondary to Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Over 18
Other, Pharmaceutical / Industry
WCTU-ZICE
NCRI-ZICE, ROCHE-ZICE, ISRCTN13914201, EU-20613, EUDRACT-2005-001710-40, NCT00326820
6.
Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
Not specified
Other
ML20115
EudraCT: 2006-000697-74, NCT00381368
7.
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
18 and over
Pharmaceutical / Industry
ML20684
NCT00502736
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute